JANSSEN - EXECUTED - C-26-18-008-3-00.PDF

RESOLUTION: C-26-18-008-3-00

OUTPATIENT SAMPLE PROGRAM WITH JANSSEN PHARMACEUTICALS, INC.
LONG ACTING INJECTABLE ANTIPSYCHOTIC MEDICATIONS

WHEREAS, an average of 200 inmate patients per month receive long acting injectable antipsychotic
(“LAI”) medications comprising of 20% of the monthly pharmacy budget for a jail population of 7500;

WHEREAS, recent medical literature indicates that adherence to antipsychotic medication may lead to a
decrease in criminal recidivism, and where patients are carefully selected for LAI treatment, in
combination with discharge planning and “warm handoffs,” there is the potential of decreasing the
recidivism of this vulnerable patient population;

WHEREAS, partnering with pharmaceutical companies to receive LAI medications free-of-charge,
Maricopa County Correctional Health Services will be able to continue these treatments on stable patients
and to initiate therapy on candidates who may benefit the most;

NOW THEREFORE:

BE IT RESOLVED that the Board of Supervisors hereby adopts Resolution: C-26-18-008-3-00 and
authorizes Maricopa County by and through its Department of Correctional Health Services (MCDCHS),
to process a non-financial Outpatient Sample Program (OSP) form (1050041-SUS170114941) with
Janssen Pharmaceuticals, Inc., for free samples of INVEGA SUSTENNA® (paliperidone palmitate), up to
six (6) units per dosage, 156 mg and 234 mg.

Dated this _ 204" day of ov ember , 2018.

IN WITNESS WHEREOF, the parties agree to enter into this agreement:

APPROVED AS TO FORM: FOR AND ON BEHALF OF
(—a) ire
Attorney for Maricopa County (to
ul }2 | [ Kx Chairman, Board of Supervisors
Date NOY 28 2019
Date
; 7 i ; ATTEST. 2)
Co Deby if Ve Card Af
WEDICPLD REETIOR = Cr Clerk of the Board OWA

KOV 268 0

beri Date

RESOLUTION: C-26-18-008-3-00

OUTPATIENT SAMPLE PROGRAM WITH JANSSEN PHARMACEUTICALS, INC.
LONG ACTING INJECTABLE ANTIPSYCHOTIC MEDICATIONS

WHEREAS, an average of 200 inmate patients per month receive long acting injectable antipsychotic
(“LAI”) medications comprising of 20% of the monthly pharmacy budget for a jail population of 7500;

WHEREAS, recent medical literature indicates that adherence to antipsychotic medication may lead to a
decrease in criminal recidivism, and where patients are carefully selected for LAI treatment, in
combination with discharge planning and “warm handoffs,” there is the potential of decreasing the
recidivism of this vulnerable patient population;

WHEREAS, partnering with pharmaceutical companies to receive LAI medications free-of-charge,
Maricopa County Correctional Health Services will be able to continue these treatments on stable patients
and to initiate therapy on candidates who may benefit the most;

NOW THEREFORE:

BE IT RESOLVED that the Board of Supervisors hereby adopts Resolution: C-26-18-008-3-00 and
authorizes Maricopa County by and through its Department of Correctional Health Services (MCDCHS),
to process a non-financial Outpatient Sample Program (OSP) form (1050041-SUS170114941) with
Janssen Pharmaceuticals, tnc., for free samples of INVEGA SUSTENNA® (paliperidone palmitate), up to
six (6) units per dosage, 156 mg and 234 mg.

pated this _ av day of Novem boew” , 2018.
IN WITNESS WHEREOF, the parties agree to enter into this agreement:
APPROVED AS TO FORM: FOR AND ON BEHALF OF
(—i) MARICO ran
Attorney for Maricopa County By (ade
{ py Board of Supervisors
fale
Date NOV 2.8 2010
Date
Co) oe C sand) / elas GZ
WEDICPLAD PEtAIBR = Ort Clerk of the Board OwIANY
MW fab [yO NOV 2 8 2h9

DPrie Date